| Symbol | GDRX |
|---|---|
| Name | GOODRX HOLDINGS, INC. |
| Sector | TECHNOLOGY |
| Region | North America |
| Industry | EDP Services |
| Address | 2701 OLYMPIC BOULEVARD, SANTA MONICA, California, 90404, United States |
| Telephone | +1 855 268-2822 |
| Fax | — |
| — | |
| Website | https://www.goodrx.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001809519 |
| Description | GoodRx is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It has over 6 million active monthly users. The companys primary focus is the U.S. prescription drug market, where GoodRx has developed a price comparison tool that it aggregates from over 200 billion daily pricing data points, directing consumers toward coupons negotiated between a pharmacy and intermediaries (pharmacy benefit managers ). GoodRx generates revenue by taking a small share of the fees paid by pharmacies to PBMs in exchange for routing consumers to these discount programs, and separately through a subscription-based model (GoodRx Gold), which offers discounted drugs to customers paying a monthly membership fee. Additional info from NASDAQ: |
(30% Negative) GOODRX HOLDINGS, INC. (GDRX) Reports Q2 2026 Financial Results
Read moreNew Form 3 - GoodRx Holdings, Inc. <b>Filed:</b> 2026-05-01 <b>AccNo:</b> 0001809519-26-000099 <b>Size:</b> 431 KB
Read moreGoodRx Expands Offerings to Now Include Ozempic® Pill for Type 2 Diabetes Patients
Read moreNew Form DEF 14A - GoodRx Holdings, Inc. <b>Filed:</b> 2026-04-29 <b>AccNo:</b> 0001809519-26-000091 <b>Size:</b> 8 MB
Read moreNew Form DEFA14A - GoodRx Holdings, Inc. <b>Filed:</b> 2026-04-29 <b>AccNo:</b> 0001809519-26-000092 <b>Size:</b> 1 MB
Read more(99% Neutral) GOODRX HOLDINGS, INC. (GDRX) Announces New Board Appointment
Read moreGoodRx Announces Date for First Quarter 2026 Earnings Release and Conference Call
Read moreMcGinnis Christopher A 🟡 adjusted position in 10.7K shares (1 derivative) of GoodRx Holdings, Inc. (GDRX) at $2.23 Transaction Date: Apr 15, 2026 | Filing ID: 000075
Read moreDirector Barnes Wendy Lynn 🟡 adjusted position in 120.5K shares (3 derivative) of GoodRx Holdings, Inc. (GDRX) at $2.23 Transaction Date: Apr 15, 2026 | Filing ID: 000074
Read more